Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017:133:77-94.
doi: 10.1016/bs.acr.2016.08.004. Epub 2016 Oct 5.

Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials

A Napoles  1 , E Cook  2 , T Ginossar  3 , K D Knight  4 , M E Ford  5
Affiliations
Review

Applying a Conceptual Framework to Maximize the Participation of Diverse Populations in Cancer Clinical Trials

A Napoles et al. Adv Cancer Res. 2017.

Abstract

The underrepresentation of ethnically diverse populations in cancer clinical trials results in the inequitable distribution of the risks and benefits of this research. Using a case study approach, we apply a conceptual framework of factors associated with the participation of diverse population groups in cancer clinical trials developed by Dr. Jean Ford and colleagues to increase understanding of the specific strategies, and barriers and promoters addressed by these strategies, that resulted in marked success in accrual of racially and ethnically diverse populations in cancer clinical research. Results indicate that the studies presented were able to successfully engage minority participants due to the creation and implementation of multilevel, multifaceted strategies that included: culturally and linguistically appropriate outreach, education, and research studies that were accessible in local communities; infrastructure to support engagement of key stakeholders, clinicians, and organizations serving minority communities; testimonials by ethnically diverse cancer survivors; availability of medical interpretation services; and providing infrastructure that facilitated the engagement in clinical research of clinicians who care for minority patient populations. These strategic efforts were effective in addressing limited awareness of trials, lack of opportunities to participate, and acceptance of engagement in cancer clinical trials. Careful attention to the context and population characteristics in which cancer clinical trials are conducted will be necessary to address disparities in research participation and cancer outcomes. These studies illustrate that progress on minority accrual into clinical research requires intentional efforts to overcome barriers at all three stages of the accrual process: awareness, opportunity, and acceptance of participation.

Keywords: Cancer clinical trials; Conceptual framework; Diverse populations; Recruitment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Conceptual Framework
See this image and copyright information in PMC

References

    1. Advani AS, Atkeson B, Brown CL, Peterson BL, Fish L, Johnson JL, Gautier M. Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study. Cancer. 2003;97(6):1499–1506. - PubMed
    1. Bernard-Davila B, Aycinena AC, Richardson J, Gaffney AO, Koch P, Contento I, Greenlee H. Barriers and facilitators to recruitment to a culturally-based dietary intervention among urban Hispanic breast cancer survivors. J Racial Ethn Health Disparities. 2015;2(2):244–255. doi: 10.1007/s40615-014-0076-5. - DOI - PMC - PubMed
    1. Brown DR, Fouad MN, Basen-Engquist K, Tortolero-Luna G. Recruitment and retention of minority women in cancer screening, prevention, and treatment trials. Ann Epidemiol. 2000;10(8):S13–21. - PubMed
    1. Bussey-Jones J, Garrett J, Henderson G, Moloney M, Blumenthal C, Corbie-Smith G. The role of race and trust in tissue/blood donation for genetic research. Genet Med. 2010;12(2):116–121. doi: 10.1097/GIM.0b013e3181cd6689. - DOI - PMC - PubMed
    1. Chen MS, L P, Dang JHT, Paterniti DA, Paterniti DA, Kelly K. Twenty years post-NIH revitalization act: enhancing minority participation in clinical trials (EMPaCT): laying groundwork for improving minority clinical trial accrual. Cancer. 2014;120(7):1091–1096. - PMC - PubMed

MeSH terms